Results 251 to 260 of about 47,543 (305)

Neck dissection after concurrent chemoradiotherapy for head and neck squamous cell carcinoma with cervical metastases

, 2008
Fumihide Rikimaru, Ryunosuke Kogo, Yuichiro Higaki, Kichinobu Tomita   +3 more
openalex   +2 more sources

A clinical study on the efficacy of concurrent chemoradiotherapy combined with targeted therapy and hyperthermia in patients with locally advanced cervical cancer. [PDF]

Transl Oncol
Jia Y, Zhang F, Zou K, Zou L.
europepmc   +1 more source

LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy. [PDF]

Cancer Immunol Immunother
Zhang Y, Zhou Z, Rui Y, Kong F, Guo Z, Zhao G, Wang J, Li J, Zhao F, Huang H, Fang F, Zhang J, Zhang T, Zhang W, Wang P, Chen X, Zhen P, Pang Q.   +17 more
europepmc   +1 more source

Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer. [PDF]

Radiat Oncol
Chen CI, Kao YK, Yang PW, Chen PC, Yang CC, Li WS, Tsai HH, Wang YJ, Lai HY.   +8 more
europepmc   +1 more source

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence [PDF]

, 2018
Badiyan, Shahed N, Cai, Chunyu, Huang, Jiayi, Khwaja, Shariq S, Wang, Xiaowei   +4 more
core   +1 more source

Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC Trial. [PDF]

Cancer Sci
Zenke Y, Shiraishi Y, Goto Y, Azuma K, Okishio K, Ogino H, Horio Y, Oizumi S, Hayama M, Nii M, Harada M, Mann H, Olivo YS, Jiang H, Senan S.   +14 more
europepmc   +1 more source

Quality of life in cervical cancer survivors after nerve-sparing radical hysterectomy, conventional radical hysterectomy or concurrent chemoradiotherapy. [PDF]

Front Oncol
Li W, Wang X, Wu M, Tan X.
europepmc   +1 more source

Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer [PDF]

, 2019
al, et, Mutch, David, Powell, Matthew A.
core   +1 more source

Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial. [PDF]

Nat Commun
Peng F, Wu J, Lian H, Wu S, Niu S, Xing X, Yang W, Song W, Li Y, Yu H, Feng ST, Wang X, Chen W, Ye W, Yu T, Liufu W, Cheng C, Bao Y.   +17 more
europepmc   +1 more source

Efficacy and safety of Chinese medicine injection combined with concurrent chemoradiotherapy in the treatment of esophageal cancer: a Bayesian network meta-analysis. [PDF]

Front Med (Lausanne)
Wang J, Xi H, Chen X, Xin Y, Wei F.
europepmc   +1 more source